rs28936383
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM3_StrongPS3_ModeratePM2_SupportingPP3PP4PP1_Moderate
This summary comes from the ClinGen Evidence Repository: The NM_000232.5: c.452C>G variant in SGCB is a missense variant predicted to cause substitution of threonine by arginine at amino acid 151 p.(Thr151Arg). This variant has been detected in at least five individuals with signs of limb girdle muscular dystrophy, including in a homozygous state (1.0 pt; PMID:30564623, 21480868, 7581448) and confirmed in trans with a pathogenic variant (c.271C>T p.(Arg91Cys), 1.0 pt, PMID:9565988) (PM3_Strong). At least one patient with this variant was clinically suspected to have limb girdle muscular dystrophy (PP4). The variant has also been shown to segregate with autosomal recessive LGMD in at least 5 affected family members in families from the Plain community in southern Indiana and has been proposed as a founder variant for this population (PP1_Moderate; PMID:7581448, 9565988, 28615891, 3083835). The minor allele frequency of this variant is 0.00006498 for European (non-Finnish) chromosomes in gnomAD v2.1.1 (1/15390), which is lower than the LGMD VCEP threshold (<0.00009) for PM2_Supporting, and therefore meets this criterion (PM2_Supporting). In vitro assays of membrane localization in HEK293 and HER-911 cells showed that expression of p.Thr151Arg in β-sarcoglycan disrupted localization of both the β-sarcoglycan subunit and the sarcoglycan complex to the plasma membrane, indicating an impact of the variant on protein function (PMID:37317968, 22095924) (PS3_Moderate). The computational predictor REVEL gives a score of 0.87, which is above the LGMD VCEP threshold of 0.70, evidence that correlates with impact to SGCB function (PP3). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/09/2025): PM3_Strong, PP4, PP1_Moderate, PM2_Supporting, PS3_Moderate, PP3. LINK:https://erepo.genome.network/evrepo/ui/classification/CA119849/MONDO:0015152/184
Frequency
Consequence
NM_000232.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGCB | NM_000232.5 | c.452C>G | p.Thr151Arg | missense_variant | 4/6 | ENST00000381431.10 | NP_000223.1 | |
SGCB | XM_047416074.1 | c.242C>G | p.Thr81Arg | missense_variant | 3/5 | XP_047272030.1 | ||
SGCB | XM_047416075.1 | c.155C>G | p.Thr52Arg | missense_variant | 3/5 | XP_047272031.1 | ||
SGCB | XM_047416076.1 | c.155C>G | p.Thr52Arg | missense_variant | 3/5 | XP_047272032.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGCB | ENST00000381431.10 | c.452C>G | p.Thr151Arg | missense_variant | 4/6 | 1 | NM_000232.5 | ENSP00000370839.6 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152034Hom.: 0 Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461426Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727054
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152034Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74224
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2E Pathogenic:6
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 17, 2023 | This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 151 of the SGCB protein (p.Thr151Arg). This variant is present in population databases (rs28936383, gnomAD 0.007%). This missense change has been observed in individual(s) with limb-girdle muscular dystrophy (PMID: 7581448, 9565988, 21480868). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 8712). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SGCB protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects SGCB function (PMID: 22095924). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | literature only | Counsyl | Feb 20, 2015 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 1995 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 16, 2022 | - - |
Likely pathogenic, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | May 31, 2018 | This variant is interpreted as a Likely Pathogenic, for Muscular dystrophy, limb-girdle, type 2E, in Autosomal Recessive manner. The following ACMG Tag(s) were applied: PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PP3 => Multiple lines of computational evidence support a deleterious effect on the gene or gene product. PS3 => Well-established functional studies show a deleterious effect (PMID:22095924) (PMID:9565988). - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 21, 2023 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 14, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at